United Therapeutics Company Insiders

United Therapeutics Management Team Effectiveness

The company has return on total asset (ROA) of 0.1244 % which means that it generated a profit of $0.1244 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.1923 %, meaning that it created $0.1923 on every $100 dollars invested by stockholders. United Therapeutics' management efficiency ratios could be used to measure how well United Therapeutics manages its routine affairs as well as how well it operates its assets and liabilities. As of 03/22/2025, Return On Tangible Assets is likely to grow to 0.17. Also, Return On Capital Employed is likely to grow to 0.22. At this time, United Therapeutics' Return On Tangible Assets are relatively stable compared to the past year. As of 03/22/2025, Return On Assets is likely to grow to 0.17, while Other Assets are likely to drop slightly above 284.7 M. As of 03/22/2025, Common Stock Shares Outstanding is likely to grow to about 50.8 M. Also, Net Income Applicable To Common Shares is likely to grow to about 878.2 M

United Therapeutics Workforce Comparison

The company has Profit Margin (PM) of 0.42 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.49 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.49.

United Therapeutics Insider Trading History

United Therapeutics Notable Stakeholders

The success or failure of an entity such as United Therapeutics often depends on how effective the management is. United Therapeutics management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of United management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the United management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.

When running United Therapeutics' price analysis, check to measure United Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy United Therapeutics is operating at the current time. Most of United Therapeutics' value examination focuses on studying past and present price action to predict the probability of United Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move United Therapeutics' price. Additionally, you may evaluate how the addition of United Therapeutics to your portfolios can decrease your overall portfolio volatility.